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Limb formationSOST is a negative regulator of bone formation, and mutations in human SOST are responsible for
sclerosteosis. In addition to high bone mass, sclerosteosis patients occasionally display hand defects,
suggesting that SOSTmay function embryonically. Here we report that overexpression of SOST leads to loss of
posterior structures of the zeugopod and autopod by perturbing anterior–posterior and proximal–distal
signaling centers in the developing limb. Mutant mice that overexpress SOST in combination with Grem1 and
Lrp6 mutations display more severe limb defects than single mutants alone, while Sost−/− signiﬁcantly
rescues the Lrp6−/− skeletal phenotype, signifying that SOST gain-of-function impairs limb patterning by
inhibiting the WNT signaling through LRP5/6.Division, Lawrence Livermore
e, CA 94550, USA.
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Sclerosteosis is an autosomal recessive form of generalized
hyperostosis (MIM 239100) due to hyperactive osteoblast activity
that results from loss of sclerostin or SOST expression. Targeted
deletion of Sost in mice causes increased bone formation and bone
strength, and administration of anti-sclerostin antibodies increases
bone formation and restores bone loss in osteoporotic rats (Li et al.,
2008a,b). For a minority of sclerosteosis patients, syndactyly of digits
(Cremin, 1979) has been described primarily as asymmetric cutane-
ous syndactyly of the index and middle ﬁngers (digits 2 and 3).
Furthermore, some patients have remarkably deformed ﬁngers with
hypoplasia and nail dysplasia (symmetric or asymmetric) most
commonly associated with the index ﬁnger (Cremin, 1979). We
have previously reported that elevated levels of human SOST in
transgenic mice cause a decrease in bone and mineral density in the
appendicular and axial skeleton. We also noted that these mice
display varying degrees of digit abnormalities ranging from fused and
split to missing digits (Loots et al., 2005). While originally SOST was
thought to primarily function in the adult skeleton as an osteocyte-
secreted factor that negatively regulates bone formation (Balemans et
al., 2001; Brunkow et al., 2001; Li et al., 2008a; van Bezooijen et al.,
2004) and promotes osteoblast apoptosis (Sutherland et al., 2004),
the hand abnormalities described for sclerosteosis patients along with
the gain-of-function limb defects suggest that SOSTmay also function
embryonically, during limb and hand formation.Based on sequence similarity, SOST was originally identiﬁed as a
member of theDAN family of cysteine-richBMPantagonists that include
DAN, Cerberus, GREM1, DAND5 (also known as CERL2, DANTE, COCO)
and its paralog SOSTDC1 (also known as ectodin, SostL, USAG-1 and
Wise) (Brunkow et al., 2001; Yanagita, 2005).While BMP2, 4, and 7 are
largely dispensable for limb patterning (Bandyopadhyay et al., 2006),
exogenous BMPs have been shown to affect the size and shape of long
bones by increasing the recruitment of progenitor mesenchymal stem
cells into the chondrogenic lineage (Duprez et al., 1996; Macias et al.,
1997). However, both noggin and gremlin, which encode antagonists of
BMP signaling, are essential for proper skeletal patterning (Benazet et
al., 2009; Brunet et al., 1998; Khokha et al., 2003).
Similarly,WNT signal transduction is essential for limb development
(Holmen et al., 2004; Pinson et al., 2000). Several WNTs have been
shown to control early events during proximal–distal outgrowth and
dorsoventral limbpatterning aswell as participate in later events during
chondrogenesis, osteogenesis, muscle development, and joint forma-
tion. Mutations in human WNT3 and WNT7A result in severe skeletal
malformations (Niemann et al., 2004; Woods et al., 2006), and several
mouse lines have beendescribedwheremisregulation ofWNT signaling
causes limb defects (Galceran et al., 1999; Parr and McMahon, 1995).
Like BMP signaling, WNT signaling is also attenuated at the receptor
level by two types of regulatory proteins. Secreted frizzled related
proteins (SFRP) directly bind to WNT ligands and prevent them from
binding to the receptor, while members of the Dickkopf family (DKK)
interact with the two WNT coreceptors, low-density lipoprotein
receptor-related proteins 5 and 6 (LRP5/6) (Niehrs, 2006; Pinzone et
al., 2009). The balance between ligands and antagonists modulate the
inputs of WNT signaling and subsequently contribute to proper limb
outgrowth, patterning, and cartilage differentiation.
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these molecules can behave both as BMP (Kassai et al., 2005;
Laurikkala et al., 2003; Winkler et al., 2003) and WNT antagonists
(Ellies et al., 2006; Itasaki et al., 2003; van Bezooijen et al., 2004; van
Bezooijen et al., 2007; Lin et al., 2009), generating some uncertainty
about their molecular action, in vivo. Our previous work has described
a transgenic mouse that overexpressses human SOST from a bacterial
artiﬁcial chromosome, where elevated levels of SOST cause osteope-
nia; we also noted that these mice display limb defects. In the current
study, we have investigated the role of SOST in limb patterning
through genetic andmolecular analyses of AER, ZPA, and limb-speciﬁc
markers of BMP and WNT signaling pathways to understand the
underlying mechanism of SOST action in the developing limb. In
addition to evidence that SOST overexpression inhibits WNT/β-
catenin signaling in vivo, we ﬁnd that overexpression of SOST in
Sosttg;Lrp6+/−mice modiﬁes the otherwise phenotypically wild-type
Lrp6+/− limb to mimic the Lrp6 knockout limb phenotype, while the
removal of Sost in Sost−/−;Lrp6−/− double knockouts signiﬁcantly
rescues Lrp6−/− skeletal phenotypes, supporting a primary role for
SOST in the inhibition of theWNT signaling pathway during the initial
stages of limb bud formation, and a critical role for ectodermal-
derived WNT signaling in the establishment of both the zone of
polarizing activity and the apical ectodermal ridge.
Results and discussion
Characterization of limb defects in Sost gain-of-function embryos
We have previously reported that increased SOST expression in
transgenic mice (Sosttg) carrying a ∼158 kb human BAC (Fig. 1A) led
to low bone mass in the appendicular and axial skeleton (Loots et al.,
2005). The observed osteopenia was shown to be gene dose-
dependent, such that transgenic mice with higher levels of SOST
exhibited a more dramatic decrease in tibial cancellous bone volume.
Sosttg transgenics also displayed gene–dose-dependent limb abnor-
malities ranging from missing digits, fused, and split digits to loss of
posterior bone structures (Loots et al., 2005; Fig. 1B and Fig. S1B and
Fig. S2). In severely affected embryos, the limb bud appeared
developmentally delayed and misshapen as early as E9.5, with
truncation along the anterior-posterior axis (AP) axis, resulting in a
cylindrical limb bud with reduced AER on the posterior side (Figs. 1c
and d). By E12.5, we observed abnormal chondrocyte condensation of
skeletal structures, and the formation of the phalanges was also
delayed, with reduced separation or lack of digit formation. By E14.5,
in most severely affected embryos, the ulna was absent, and digits 2 to
5 often failed to form (Fig. S1A).
Scoring of 117 neonates (77 Sosttg and 40 wild-type; derived from
Sosttg×Sosttg and Sosttg×wt matings) revealed that Sost gain-of-
function most dramatically perturbs the autopod and zeugopod
patterning along the A–P axis, where digit 5 (the most posterior
autopod skeletal structure) was missing in 87% of Sosttg embryos. The
ulna was absent from at least one forelimb in 22% of the Sosttg
embryos, and 11% of Sosttg embryos completely lacked all autopod and
zeugopod skeletal elements. The humerus and scapula were never
affected, even in the most severe cases (Fig. 1B). We also observed a
left–right asymmetry, such that the left forelimb and right hindlimb
were more severely affected (Fig. S1B). To correlate the severity of
digit abnormality with BAC copy number or zygosity, we examined
human SOST expression in E11.5 limb buds derived from matings of
phenotypically normal but hemizygous parents. Following Mendelian
ratios, 25% of embryos were genotypically wild-type and 75% were
Sosttg. On average, one third of Sosttg limb buds were affected
(resembling the embryo depicted in Fig. 1e, top panel) and the rest
were phenotypically wild-type (resembling the embryo depicted in
Fig. 1e, bottom panel). Using quantitative RT–PCR, we examined
human SOST expression levels in pooled Sosttg embryos and found100% of the affected embryos to have ∼2× the amount of human SOST
expression detected in phenotypically normal Sosttg embryos, con-
ﬁrming that the severity of limb defects correlates with Mendelian
inheritance ratios, BAC zygosity, and human SOST expression levels
(Fig. S2).
To examine whether human SOST was expressed according to the
morphological changes in limb patterning, as well as whether it
faithfully recapitulated the endogenous mouse Sost expression, we
used in situ hybridization in wild-type or human SOST transgenic mice
and β-galactosidase activity in mice where murine Sost has been
replaced by LacZ. Supporting the validity of the LacZ expression, we
found the knock-in expression to recapitulate mouse Sost expression
monitored by in situ hybridization but with better signal-to-noise ratio
(Figs. S3E, F); therefore, we used LacZ embryos to monitor mouse Sost
expression. For both human and mouse Sost, we observed a dynamic
pattern of expression that began during the initial stages of limb bud
formation (∼27-somite stage), where Sost was found to be expressed
throughout the dorsal and ventral limb ectoderm (Figs. 1 and 2Q;
Fig. S3). At E10.5, the expressionwas signiﬁcantly higher on the ventral
side, extended proximally to the trunk, while on the dorsal side, it was
concentratedmore distally, but excluded from the AER (Figs. 1d–f). This
pattern continued until E12.5, when expression became distally
restricted, although SOST expression continued to be excluded from
the AER (Fig. 1f). Generally, murine and transgenic human SOST
expression mirrored each other, with slight qualitative differences
(Fig. S3), while quantitatively (using quantitative RT–PCR), we found
endogenous mouse Sost expression to be 2-fold less than transgenic
human SOST expression in defective embryos (Fig. S2).
To ensure the limb defects observed in Sosttg embryos result from
high levels of SOST in its endogenous expression domain, rather than
spatiotemporal misexpression of human SOST, we examined Sosttg ;
Sost −/− embryos. We anticipated that limb defects resulting from an
overdose will be fully or partially rescued by the lack of mouse Sost in
Sost−/− embryos. All Sosttg; Sost−/− embryos examined (N=9)were
fully rescued. Among Sosttg; Sost +/− embryos 60% (N=21)were fully
normal and 40% (N=14) had mild digit abnormalities (Table S1),
suggesting that Sost −/− complements the limb defects caused by
SOST overexpression in Sosttg transgenic embryos.
Repression of ZPA and AER genes in Sosttg limb buds
The loss of posterior skeletal elements observed in severely
affected Sosttg animals (Fig. 1B) was highly reminiscent of twomutant
strains:Wnt7A (Parr andMcMahon, 1995) and Shh (Kraus et al., 2001)
where digits 2–5 and the ulna were absent, while other proximal
skeletal elements were unaffected. This suggested that elevated levels
of SOST interfere either with establishing or maintaining the ZPA
function to regulate digit formation and identity through the SHH
morphogen (Ahn and Joyner, 2004; Kraus et al., 2001). Similar to limb
buds deﬁcient inWnt7a, which is also expressed in the ectoderm, Shh
expression was dramatically reduced in Sosttg limb buds (Figs. 2A–D).
The decrease in Shh expression was variable from embryo to embryo,
consistent with the range of loss of posterior skeletal elements
observed in older animals (9/9 defective and 4/9 phenotypically
normal Sosttg embryos showed reduced Shh limb expression by in situ
hybridization). Despite ectodermal restriction of Sost expression and
absence from the AER (Fig. 2Q; Fig. S3), AER gene expression was also
affected in Sosttg and Sost−/− embryos. Both Fgf4 (Figs. 2E–H) and Fgf8
(Figs. 2I–L) were downregulated in Sosttg (11/11 defective and 7/13
normal Sosttg embryos showed reduced Fgf4 limb expression by in
situ; 12/12 defective and 9/18 normal Sosttg embryos showed
reduced Fgf8 limb expression by in situ). In particular, both Fgf-4
and -8 expression domains were narrower along the dorsoventral axis
in Sosttg limb buds (Figs. 2F′ and J′, red arrow) and wider in Sost−/−
limb buds (Figs. 2G′ and K′, green arrow), suggesting that Sost
contributes to the establishment of the AER domain. While in situ
Fig. 1. Limb defects and human Sost expression in the Sosttg developing limb. (A) A 158 kb human transgene spanning the Sost andMeox1 transcript was used to generate the Sosttg
gain-of-function allele (Loots et al., 2005). (B) Skeletal preparations of E17.5 wild-type and Sosttg embryos where Sost gain-of-function results in progressive loss of skeletal elements
from posterior to anterior. A limb was scored as abnormal if it fell outside of the range observed in wild-type samples; 117 total animals were scored consisting of 77 Sosttg and 40
wild-type (d digit, ra radius, ul ulna, tg transgenic, wt wild-type). (C–F) Human Sost expression was visualized by in situ hybridization using a human speciﬁc Sost probe, in a time
course panel of E9.5 to E12.5 Sosttg embryos. At each time point whole embryo (C–F), and dorsal limb and AER views are provided (c–f). Dorsal limb bud views are provided for two
different Sosttg littermate embryos at each time point, where the top limb corresponds to a severely affected embryos and the bottom limb is from a Sosttg embryo that is
morphologically indistinguishable from a wild-type limb bud). Asterisk highlights developmentally delayed mutant limb bud; arrowhead points to AER. ﬂ forelimb, hl hindlimb, nf
neural folds, sc spinal cord, mb midbrain, fb forebrain, def defective, tg transgenic.
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Sost−/− embryos (Fig. 2K′), quantitative measurements (by quanti-
tative RT–PCR) showed Fgf8 mRNA to be also reduced in embryos
lacking Sost (Fig. 2L), possibly due to loss of Fgf8 expression in the
anterior AER (Fig. 2K, black arrows). Despite the observed dorsoven-
tral expansion, we attributed the decrease in Fgf8 expression in
Sost−/− embryos to the weaker expression per cell and a more
restricted anterior-posterior expression domain.Although loss of Shh has been reported to result in decreased
Grem1 expression levels (Litingtung et al., 2002) at E10.5 (Fig. 2P), we
found no quantitative change in Grem1 expression in Sosttg embryos.
However, the Grem1 expression domain expanded posteriorly into
the region that lacks Shh positive cells (Figs. 2N and N′, red arrow),
consistent with the observation that Shh descendants lack the ability
to express Grem1 (Scherz et al., 2004) (Figs. 2M–O). We also observed
a strong shift in Grem1 expression domain on the ventral side (the
Fig. 2. Repression of ZPA and AER genes in Sosttg. (A–D) Shh, (E–H) Fgf4, and (I–L) Fgf8 were signiﬁcantly downregulated in Sosttg E10.5 limb buds. Shh was down to 20% its normal
expression level in Sosttg, but unaffected in Sost–/– embryos (D). Fgf4 and Fgf8 were downregulated in both Sosttg and Sost–/– embryos (H, L); the AER width was dependent on Sost
levels, such that high levels of Sost limited its domain (J′, red arrow), while the absence of Sost disorganized and expanded it dorsoventrally (K′, green arrow). (M–P) Grem1, a
mesenchymal marker, while quantitatively appeared unaffected (P), its expression domain (N, O) was altered in both gain- and loss-of-function embryos. In Sosttg embryos Grem1
domain was expanded posteriorly (N′, red arrow), along with an anterior reduction on the ventral side (N′, green arrow). In Sost–/– embryos similar asymmetric, but more subtle
changes were observed (O′). (Q) Sost expression is restricted to the limb bud ectoderm. (R) Limb bud sections were carried out as illustrated.
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(Fig. 2Q), where in both Sosttg (Fig. 2N′) and Sost−/− (Fig. 2O′)
embryos Grem1 expression was excluded from the anterior region.
Genetic evidence of SOST as a WNT inhibitor
SOST was initially characterized as a BMP antagonist and, more
recently, as a WNT antagonist. To determine if SOST favors the
inhibition of BMP, WNT, or both of these pathways, in the limb, we
examined genetic interactions between Sost gain- and loss-of-
function alleles and Grem1, Lrp5, or Lrp6 knockout alleles. The protein
products of these genes are well- established components of the
canonical BMP and WNT signaling pathways, respectively, and these
mutants show limb defects of a similar nature to those observed in the
Sost gain-of-function transgenic mice.
We reasoned that if secretion of SOST and GREM1 proteins
primarily inhibit BMP signaling in the adjacent AER through
epithelial–mesenchymal interactions (Michos et al., 2004; Panman
et al., 2006), they may have redundant functions during limb
patterning, such that elevated levels of SOSTwould potentially rescue
the Grem1−/− phenotype. Our rationale was based on the observation
that both Noggin and Gremlin are BMP antagonists expressed in the
limb bud which have the ability to interchangeably rescue gene
expression changes in the limb bud of ld mutant mice (Khokha et al.,
2003; Zuniga et al., 1999), yet their physiological roles in the limb bud
are different, and their null phenotypes are distinctive (Brunet et al.,
1998; Khokha et al., 2003; Zuniga et al., 1999). Alternatively, if SOST
inhibits the canonical WNT pathway through one or both of the LRP
receptors, elevated levels of SOSTwouldmodify the Lrp5 and Lrp6 limb
knockout phenotypes. We found that elevated SOST expression fails to
rescue but rather exacerbates the Grem1−/− phenotype where 40% of
Sosttg;Grem1−/− embryos (4 of 10) lack most autopod structures, and
the zeugopod consists of a truncated bone fused to a dramatically
shortened humerus (Fig. 3D and Table 1), indicating that Sost and
Grem1 are not acting in the same molecular pathway.
In contrast, we found that SOST shows strong interactions with the
WNT pathway, consistent with SOST acting as a WNT inhibitor via its
interactions with the WNT coreceptors LRP5 and LRP6 (Ellies et al.,
2006; Itasaki et al., 2003; Li et al., 2005). Reduction of LRP function
results in limb defects (Holmen et al., 2004) such that 35% of Lrp5+/−;
Lrp6+/− and 72% of Lrp5−/−;Lrp6+/− are affected, where the severity
follows the left to right and anterior–posterior axis, highly similar to
Sosttg phenotype (Figs. 1B and 3 and Table 1). Consistent with the idea
that LRP6 is the more important receptor in the embryo, Lrp6−/−
mutants display strong effects in the limb, while Lrp5−/− limbs
develop normally. We found that Sosttg;Lrp6+/−mice have enhanced
limb abnormalities closely resembling those of Lrp6−/− limbs, relative
to either Lrp6 heterozygotes, which look phenotypically normal, or
Sosttg strain, suggesting that SOST inhibits LRP5/6 receptors (Fig. 3F).
20% of Sosttg;Lrp6+/− embryos also displayed spina biﬁda and tail
truncation phenotypes similar to Lrp6−/− homozygotes (Table 1; data
not shown), suggesting that SOST also inhibits WNT signaling in the
nervous system, consistent with Sost expression pattern (Figs. 1C–E).
In addition, we observed a mild enhancement of the Sosttg phenotype
when LRP5 was reduced in Sosttg;Lrp5−/− embryos (Table 1) as
further evidence that SOST interacts with both LRP5 and LRP6
coreceptors during limb development.
We also reasoned that elimination of the putative WNT antagonist
SOST would elevateWNT signaling and rescue the limb phenotypes of
Lrp5/6 mutants. Lrp6−/− forelimbs have a dramatically shortened
zeugopod with one bone and two digits (Fig. 3E) while the hindlimbs
lack the autopod and ﬁbula and show fused hip bones (Fig. 3J). We
found Sost−/−;Lrp6−/− mice to have signiﬁcantly rescued skeletons,
where the forelimbs lack only digit 5 (Fig. 3H, compare to Fig. 3E). A
more dramatic rescue was observed in the hindlimbs, where the
absence of SOST resulted in hindlimbs that lack only 1–2 digits(Fig. 3K), in contrast to the complete lack of autopods in Lrp6−/−
mice. Although reduced in size, the ﬁbula was also restored in these
animals, and the ilium bones were fully separated. Lrp6−/−mice also
have small heads, small eyes (microophthalmia), and cleft upper and
lower lips, lack tails, and display different degrees of spina biﬁda
(Pinson et al., 2000). The removal of SOST in Sost−/−;Lrp6−/− mice
ameliorated some of these defects (Fig. S4), but the most dramatic
rescue was evident in the appendicular skeleton, where SOST rescued
the hand and feet defects (Figs. 3H and K); this evidence demonstrates
that SOST genetically interacts with the WNT signaling pathway
during limb and skeletal development. Mechanistically, the loss of
SOST, which normally interferes with WNT signaling, releases
inhibition on other LRP receptors (possibly LRP5), allowing them to
compensate for and partially rescue the complete loss of LRP6
receptor. In contrast, removing SOST in Sost−/−;Grem1−/− double
knockouts did not rescue Grem1−/− autopod defects (data not
shown).
Disruption of ectodermal and mesnchymal WNT signaling in the Sosttg
limb bud
To determine whether both Sosttg and Lrp6−/− limb defects may be
mediated by the same direct or indirect molecular perturbations, we
compared transcript levels in E10.5 forelimb buds of several key
regulators thought to be involved in ourmodel ofWNT antagonism.We
found levels of Shh and its target gene dHand to be ∼20% and ∼50% of
normal expression in both Sosttg and Lrp6−/− limbbuds (Figs. 4A andB).
To determine whether both Sosttg and Lrp6−/− defective limbs both
have reduced WNT signaling activity, we used quantitative RT–PCR to
examine expression of Axin2, a direct target ofWnt/β-catenin signaling
(Jho et al., 2002). Axin2 transcript levels were signiﬁcantly decreased in
Sosttg and Lrp6−/− mutant limb buds (Fig. 4C), adding to the evidence
that SOST inhibits the canonical WNT pathway in the limb.
Furthermore, we quantiﬁed transcript levels of 168 genes related
to WNT and BMP function using quantitative RT–PCR arrays
(Table S2). Nine genes were downregulated ≥1.5-fold in Sosttg in
each array, of which Ctbp1, Jun andWnt7A, Bmp2, Tgfbi and Bmp5 had
signiﬁcant P values. Inhibin alpha was the only gene upregulated in
Sosttg embryos, but no BMP-related transcripts were signiﬁcantly
upregulated in Sost−/−. In contrast, while noWNT-related transcripts
were elevated in Sosttg, Tcf3 transcription factor, a terminal
component of the WNT signaling pathway that has been shown to
function as a repressor (Cole et al., 2008), was signiﬁcantly
upregulated in Sost−/−. The up-regulation of a repressor may explain
the mild effect on downstream WNT targets, suggesting a protective
autoregulatory mechanism for an overactive WNT pathway in the
absence of Sost in the limb. Tcf3 potentially curbs the overactive WNT
signaling due to elevated levels of Wnt5A and Wnt7A transcripts and
activated β-catenin protein detected by in situ and immunohisto-
chemistry, respectively (data not shown).
To address how SOST interferes with WNT signaling regionally in
the limb, we crossed the SOST gain-of-function transgene to the WNT
reporter BatGal mouse (Maretto et al., 2003) and examined WNT
responsiveness in the ectoderm, mesenchyme, and apical ectodermal
ridge of the limb. At embryonic day 10.5, the LacZ stain of limb buds
viewed in whole BatGal and Sosttg;BatGal embryos initially looked
indistinguishable and consistent with previously published limb
patterns (Maretto et al., 2003), where the dominant expression of
LacZ is in the AER (Figs. 5A and A′). Upon clearing, dissecting the limb
buds and examining LacZ expression at higher magniﬁcation, and in
sections, we observed a decrease in LacZ-positive cells in both the
dorsal and ventral ectoderm and mesenchyme (Figs. 5B–F and B′–F′),
within or immediately adjacent to the ectoderm that expresses the
highest levels of SOST (Fig. 5G). These results suggest that
ectodermal-derived SOST inhibits WNT signaling in both the
ectoderm and the neighboring mesenchyme. β-Catenin is critical for
Fig. 3. Sost gain-of-function modiﬁes both Grem1−/− and Lrp6−/− limb phenotypes, but Sost loss-of-function rescues only Lrp6−/−. (A–H) Skeletal preparations of wild-type or Lrp6+/−
(A), Sosttg (B),Grem1−/− (C), Sosttg;Grem1−/− (D), Lrp6−/− (E), Sosttg;Lrp6−/− (F), Sost−/− (G), and Sost−/−;Lrp6−/− (H) forelimbs. About 40% of Sosttg;Grem1−/− (D) forelimbs lackedan
elbow, where the humerus, radius, and ulna have formed one skeletal element (arrow) and the wrist and autopod were highly reduced and lack most digits (bracket). While Lrp6
heterozygous forelimbs were indistinguishable from wild-type, Sosttg modiﬁed the Lrp6 phenotype (E) such that Sosttg;Lrp6+/− forelimbs were indistinguishable from Lrp6−/− (F).
Removal of Sost in the absence of Lrp6 receptor resulted in dramatic rescue of Lrp6−/− limbphenotype (H).Most dramatic rescue of Lrp6–/–was observed in the hindlimbs (I,J),where lack
of Sost restored hip morphology and autopod structure in Lrp6–/– mice (K). Digit 5 marked by an asterisk was never restored in autopods in Sost–/–;Lrp6–/– mice (H, K).
174 N.M. Collette et al. / Developmental Biology 342 (2010) 169–179transducing canonical WNT signals to the nucleus of responding cells,
where it participates with Lef/Tcf transcription factors in the
activation of downstream target genes (Behrens et al. 1996; Molenaar
et al. 1996). It has been previously reported that the removal of β-
catenin from the limb bud ectoderm results in severe limb defects
characterized by lack of hindlimbs and severely truncated forelimbs(Barrow et al., 2003). These ﬁndings support the notion that
ectodermal WNT signaling is required for proper AER function.
While the BatGal mice are limiting in this regard, since they express
LacZ at very low levels in the ectoderm, our results favor the
conclusion that WNT signaling in both the ectoderm and the
underling mesenchyme is abolished by SOST overexpression.
Table 1
Genetic analysis of Sost gain-of-function mutations in combination with mutations in members of the Wnt and Bmp signaling pathways.
Genotype N Forelimb Hindlimb Other
Sosttg×Grem1−/−
Sosttg 6 Normal Normal
13 Loss of digits (3–4d rF, 3–5d lF) Normal
1 Loss of digits (3d bF) Loss of digits (1d lH)/Loss of ﬁbula (lH)
Grem1+/− 17 Normal Normal
Grem1−/− 10 Fused radius/ulna Loss of ﬁbula
Loss of digits (3d bF) Loss of digits (0–3d bH)
Sosttg;Grem1+/− 17 Normal Normal
3 Loss of digits (2–4d rF, 3–5d rF)
6 Loss of digits (3–4d rF, 3–5d lF) Loss of digits (3–4d lH)
Sosttg;Grem1−/− 6 Fused radius/ulna Loss of ﬁbula/digits (0–3d bH)
Loss of digits (3d bF)
4 Fused ulna/shortened humerus Truncated tibia/no digits/Loss of ﬁbula
Sosttg×Lrp5−/−
Sosttg 14 Normal Normal
16 Loss of digits (2–4d bF) Normal
2 Loss of ulna/digits (2–3d bF) Loss of digits (1d lH)/Loss of ﬁbula
Lrp5+/− and Lrp5−/− 31 Normal Normal
Sosttg;Lrp5+/− 21 Loss of digits (2–4d rF, 3–4d lF) Normal
3 Loss of ulna/digits (2–4d bF) Normal Curly tail
Sosttg;Lrp5−/− 3 Loss of digits (4d rF) Normal
5 Loss of digits (2–3d bf) Loss of digits (3–5d bH) Curly tail; runty; neonate death
Sosttg×Lrp6+/−
Sosttg 6 Normal Normal
14 Loss of digits (2–4d bF) Normal
Lrp6+/− 23 Normal Normal
Lrp6−/− 11 Loss of ulna (lF)/short radius Truncated femur/no digits Spina biﬁda; no tail
Loss of digits (4d rF, 2d lF) Abnormal/fused pelvis
Cleft jaw/palate
Microcephalya; microopthalmiaa
Sosttg;Lrp6+/− 25 Loss of digits—mild (2–5d bF, s lF) Loss of digits (3–5d bH)
Dorsal ectopic nails Dorsal ectopic nails
9 Loss of digits—severe (1–3d bF) Truncated/no digits Spina biﬁda
Curly/truncated tail
Lrp5−/−×Lrp6+/−
Lrp5+/− and Lrp6+/− 30 Normal Normal
Lrp5+/−;Lrp6+/− 19 Loss of digits (4d rF, small d5 lF) Normal
Lrp5−/−;Lrp6+/− 7 Loss of digits (2–3d bF) Normal
Sost−/−×Lrp6+/−
Sost+/− and Sost−/− 27 Normal Normal
Lrp6+/− 22 Normal Normal
Lrp6−/− 11 Loss of ulna (lF)/short radius Truncated femur/no ﬁbula Spina biﬁda, no tail
Loss of digits (4d rF, 2d lF) Lack of feet Abnormal/fused pelvis
Bilateral cleft jaw/palate
Microcephalya; microopthalmiaa
Sost+/−;Lrp6+/− 18 Normal Normal
Sost−/−;Lrp6+/− 10 Normal Normal
Sost−/−;Lrp6−/− 8 Loss of digit (4d bF) Loss of digits (3–4d bH) Spina biﬁda, no tail
Loss of ﬁbula (rH) Unilateral cleft palate
d digit, F forelimb, H hindlimb, r right, l left, b both, s syndactyly.
a Rescue of phenotype was not quantiﬁed in Sost−/−;Lrp6−/−.
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anterior–posterior patterning
Our data show that elevated levels of SOST impair limb patterning
along the A–P axis, where the most posterior digit 5 and the most
posterior zeugopod element, the ulna, are often absent or abnormal in
Sosttg. We attribute these effects to excessive inhibition of WNT
signaling, resulting in misregulation of genes in the two key limb
centers, the zone of polarizing activity and the apical ectodermal
ridge. Using theWNT signaling reporter BatGal, we were able to show
that ectodermal expressed SOST suppresses WNT signaling both
ventrally and dorsally, with the most dramatic down-regulation on
the ventral side (where SOST is more highly expressed) where BatGal
transgene signal is completely obliterated in the distal ectoderm and
mesenchyme. On the dorsal side, BatGal transgene is expressed both
in the proximal and distal mesenchyme (and in the ectoderm at very
low levels), and consistent with SOST crescent moon expressionpattern, BatGal transgene is repressed by SOST primarily in the distal
region (mesenchyme and ectoderm). BatGal, as previously reported, is
also expressed in the AER, region devoid of SOST expression, and in
our gain-of-function allele, we observe an enhancement in LacZ AER
expression (Figs. 5B′, D′, and F′, black arrow) when SOST is
overexpressed in the neighboring ectoderm. Based on these changes
in expression pattern of theWNT reporter, we can speculate that a net
reduction in WNT signaling in the distal mesenchyme and ectoderm
(both from the ventral and dorsal regions) results in an overall
reduction of SHH expression level in the ZPA, suggesting that WNT
signaling in distal mesenchyme/ectoderm is required for either
establishing or maintaining SHH expression in the posterior mesen-
chyme of the developing limb. Since SHH turns on at E9.75, and most
of our analysis was carried out at E10.5, we cannot differentiate
between these two possibilities, nor can we determine if there is a
delay in SHH activation. SHH has also been recently shown to be
directly affected by β-catenin signaling, in that reduced β-catenin
Fig. 4. Inhibition of Shh and WNT signaling in both Sosttg and Lrp6−/− limb buds. (A–C) Limb bud RNA was isolated from wild-type, Sosttg, and Lrp6−/− E10.5 limb buds. Normal
expression of Shh (A) and its downstream transcriptional target dHand (B) was dramatically reduced in both Sosttg and Lrp6−/− embryos. Similarly, Axin2 expression, a downstream
target of canonical WNT signaling, was less than 50% of normal levels in both Sosttg and Lrp6−/− embryos (C).
176 N.M. Collette et al. / Developmental Biology 342 (2010) 169–179signaling also directly reduces SHH expression (Miyagawa et al.,
2009). Our ﬁndings are in support of WNT signaling acting upstream
of SHH and positively regulating SHH transcription.Fig. 5. Ectodermal SOST inhibits WNT signaling in the mesenchyme. (A–F) WNT activity in
WNT reporter transgene was examined in E10.5 wild-type (A–F) and Sosttg (A′–F′) embryos
and F′), dorsal (D and D′), and ventral (E and E′) limb bud views. Ectodermal-derived SOS
ectoderm (E and E′) in a pattern consistent with human SOST transgene expression (yellow
region). AER LacZ expression was unaffected or enhanced in the presence of SOST (B′, D′, and
indicate morphogenic activity of ectodermal-derived SOST to suppress WNT signaling in thIn parallel, we observed gene expression changes in the AER,
where both Fgf8 and Fgf4 were found to be signiﬁcantly repressed
(Figs. 2E–L) in response to elevated levels of SOST. Since SOST isthe limb was examined in BatGal WNT reporter mice. LacZ expression from the BatGal
in whole mount (A and A′), AER limb views (B and B′), transverse limb sections (C, C′, F,
T (G) repressed BatGal LacZ reporter expression in the dorsal (D and D′) and ventral
dashed region). On the ventral side all reporter activity was lost (E′ and F′, red dashed
F′). Black arrows indicate the AER, the region where SOST is absent (G), orange arrows
e underlining mesenchyme.
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these molecular changes could have emerged. One possibility is that
ectodermally expressed SOST inhibits ectodermal WNT signaling to
interrupt the WNT3/β-catenin/FGF regulatory loop shown to be
essential for AER establishment andmaintenance (Barrow et al., 2003;
Hill et al., 2006). The limb bud ectoderm represents a major source of
WNT ligands (Witte et al., 2009); therefore, it is possible that SOST
prevents WNT ligands such as WNT3 from binding to the LRP5/6
receptors within the ectoderm to attenuate WNT signaling in this
tissue. Barrow et al. have shown that when they conditionally
removed either Wnt3 or β-catenin from the limb ectoderm using
Msx2Cre, the mice display severe limb defects highly similar to both
Sosttg and Lrp6−/− limbs. In addition, Hill et al. observed that loss of
mesenchymal β-catenin activity in the developing limb bud resulted
in reduced expression of AER marker genes despite persistent β-
catenin activity in the AER of the developing limb. While they
reported severe limb truncations, we report varying degrees of
posterior limb defects, and no distal truncations. This is likely due to
the timing of and the extent of the loss of β-catenin activity, since in
our model the loss of β-catenin /WNT signaling in the mesenchyme is
incomplete, resulting in a less severe phenotype. While we observed
very low levels of ectodermal LacZ expression in the BatGal mice, we
cannot rule out that WNT signaling is not affected in the ectoderm,
since our results are constrained by the restricted expression pattern
of the BatGal transgene, which may not fully recapitulate the
endogenous WNT activity.
Since limb development proceeds as a tightly coordinated series of
morphogenic exchanges between various signaling centers, with very
little cell autonomous activity, our results could also be explained as a
modiﬁcation of the ectoderm–ZPA–AER regulatory loop, where
ectodermal and/or mesenchymal WNT signaling is required for SHH
activity, and a dramatic reduction in SHH (we found SHH to be
expressed at ∼20% of normal levels in Sosttg and Lrp6−/− limb buds;
Fig. 4A) interferes with both ZPA and AER function. The proposed
model of SOST action is similar and consistent with previously
reported WNT signaling in the limb, whereby epithelial–mesenchy-
mal interactions allow for transduction of signaling effects into
neighboring tissues (ten Berge, et al., 2008). It has also been shown
that SHH protein is present not only as a posterior gradient in the
mesenchyme but also diffuses to the ectoderm and that posterior
derived skin cells are derived from SHH-responsive cells (Gritli-Linde
et al., 2001, Ahn and Joyner, 2004). Our results suggest that SOST is
secreted by ectoderm and acts on the adjacent mesenchymal cells, a
mode of action consistent with SOST's role during bone metabolism
where osteocytes deeply buried in the bone secrete SOST, which
travels to the surface of the bone where osteoblasts reside and inhibit
their mineralization function (Balemans et al., 2001; Brunkow et al.,
2001; Li et al., 2008a; van Bezooijen et al., 2004).
The changes in expression seen in BatGal and Grem1 in the
presence of the SOST transgene would suggest that there are
dorsoventral patterning defects as well. No obvious dorsoventral
mispatterning was observed in Sosttg mice. However, Sosttg;Lrp6+/−
mice did display ventralization of the dorsal autopod in the form of
ectopic nails on the dorsal surface, and Sost−/−mice displayed ectopic
pigment and hair on the ventral autopod (data not shown),
suggesting dorsalization, which are consistent with perturbations in
WNT signaling presented in Fig. 5.
Our ﬁndings are also consistent with recent reports that BMP
signaling negatively regulates bone mass by induction of sclerostin
which then inhibits the canonicalWNT pathway (Kamiya et al., 2008).
When Sosttg mice were crossed to Grem1 mice which have limb
defects as a direct result of overactive BMP signaling, SOST failed to
compensate for the loss of Grem1 and zeugopod and autopod
formation was even further impaired. In contrast, when Sosttg mice
were crossed to Lrp5+/− and Lrp6+/−mice, Sosttg;Lrp6+/− compound
mice displayed defects that are more severe than those in Lrp5−/−;Lrp6+/− limbs, while the absence of Sost in Sost−/−;Lrp6−/− limbs
dramatically improves skeletal patterning, providing genetic evidence
that Sost functions as a WNT antagonist during limb skeletogenesis.
While our ﬁndings establish SOST as a WNT antagonist in the limb by
these genetic criteria, we cannot rule out the possibility that SOST has
some BMP-antagonistic activity, as previously suggested. One possible
reason for the discrepancies between the previous data, where SOST
was shown to inhibit the BMP pathway could be explained by a dual,
context-dependent role of SOST, such that SOST afﬁnity for one
pathway is tissue-dependent.
Since WNT signaling is implicated in a multitude of processes and
WNT ligands are broadly expressed spatially and temporarily during
vertebrate limb development, inhibitors of WNT signaling play an
important role as gatekeepers of signal transduction and cell–cell
communication across tissues. It is increasingly clear that a balanced
combination of ligand expression and antagonistic regulation is
required to ensure accurate WNT signaling and therefore proper
limb outgrowth, patterning, and cartilage differentiation. Here we
have shown that in addition to the pervasive high bone mass
phenotype recorded for sclerosteosis patients and Sost knockout
mice, SOST also contributes to the robustness of limb patterning
signals by weakening the signal transduced through the LRP/6
receptors.Materials and methods
Generation of compound mice
Sosttg, Grem1, Lrp5, Lrp6, BatGal, and Sost mutant mice have been
previously described (Holmen et al., 2004; Khokha et al., 2003; Li
et al., 2008a; Loots et al., 2005; Maretto et al., 2003). Sost KOMP
knockout mice were generated by a LacZ replacement of the entire
Sost open reading frame. Sosttg or Sost−/−mice were mated to BatGal
individual knockout strains and the progeny were genotyped by PCR
(primer sequences and PCR conditions available upon request).
Progeny were selected for Sosttg; BatGal, Sosttg;hets, or double hets
and were mated to each other in timed matings; embryos were
collected at E9.5, E10.5, E11.5, E12.5, E14.5, and/or E17.5, depending
on the desired analysis, and the embryonic sac was genotyped by PCR.
E0.5 of gestation was considered as noon on the day a visual
copulatory plug was observed. Staging of embryos was veriﬁed
where possible (before E12.5) by counting somites. All animal
experiments were carried out in accordance with guidelines set by
the Animal Care and Use Committee at University of California-
Berkeley and Lawrence Livermore National Laboratory.Whole-mount in situ hybridization
Whole-mount in situ hybridizations were carried out using
standard procedures (Khokha et al., 2003). Species-speciﬁc
sequences of human and mouse Sost were cloned from the 3′UTR
region of each cDNA (human Sost NM_02537.2; mouse Sost
NM_024449.4). Brieﬂy, digoxigenin-labeled antisense RNA probes
were generated to the desired RNA sequence and hybridized to
whole-mount embryos. Expression was visualized by biding BM
Purple (Roche). Antisense RNA probes for Grem1 (MluI–SacII
fragment of NM_011824), Fgf8 (PstI 3′ cDNA and UTR fragment of
NM_010205; see Crossley and Martin, 1995), Fgf4 (NM_01202.5),
and Shh (MscI–NarI fragment of NM_009170; see Echelard et al.,
1993) were generated as described (Hogan et al., 1994) with the
following modiﬁcation: proteinase K digestion was omitted for
ectodermal or AER probes. A minimum of 4 embryos were used per
genotype, per experiment. Wild-type controls were obtained from
the same litter, whenever possible.
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LacZ stains embryos were dissected free of extraembryonic
membranes into ice-cold 1× phosphate-buffered saline (PBS), pH
7.3. Embryos were ﬁxed in 2% paraformaldehyde, 0.2% glutaraldehyde
in 1× PBS, 2 mM MgCl2 at 4 °C for 30 minutes to 1 hour, followed by
extensive rinsing in 1× PBS, 2 mM MgCl2. Embryos were stained for
4 hours (BatGal) at RT or overnight (Sost−/−) at 4 °C in X-gal stain:
1 mg/ml X-gal, 2 mM MgCl2, 5 mM EGTA, 0.02% Nonidet P-40, 5 mM
potassium ferrocyanide, 5 mM potassium ferricyanide, in 1× PBS, pH
7.3. After staining, embryos were postﬁxed in 4% paraformaldehyde in
1× PBS, pH 7.3 at 4 °C, and then cleared in glycerol for photography.
Skeletal preparations
Skeletal preparations were made of E17.5 day mouse embryos
using Alcian Blue 8GX for cartilage and Alizarin Red S for bone
following established protocols. Embryos were dissected free of
internal organs, and skin, and ﬁxed in 95% ethanol followed by stain
in 0.05% Alcian Blue 8GX, 80% ethanol, 20% glacial acetic acid. Excess
stain was washed out, and embryos were then stained in 60 mg/L
Alizarin Red S, 1% potassium hydroxide (KOH), 25% glycerol followed
by clearing in 1% KOH and 25% glycerol and storage in glycerol for
photography. For skeletal preparation, whole litters were analyzed.
Quantitative RT–PCR
Total RNA was isolated from limb buds using Qiagen methods and
reverse-transcribed into cDNA (Superscript II, Gibco). Quantitative
RT–PCR expression analysis was performed using an ABI Prism
7900HT sequence detection system, TaqMan® Universal PCR Master
mix, eukaryotic 18S rRNA predeveloped TaqMan® assay reagent for
normalization and TaqMan® Assay-on-Demand™ products for mouse
and human Sost, and murine Fgf4, Fgf8, Shh, Grem1, dHand, and Axin2
(Applied Biosystems). For microarrays, 250 to 1000 ng of total RNA
from E10.5 forelimbs was converted into cDNA using RT2 First Strand
Kit (SA Biosciences), which included a genomic DNA elimination step.
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